Literature DB >> 3015005

Evolution and spread of IncFIV plasmids conferring resistance to trimethoprim.

I G Campbell, B J Mee, S M Nikoletti.   

Abstract

Twenty-one IncFIV-group plasmids conferring trimethoprim resistance in Escherichia coli isolates from humans and pigs were examined. Three evolutionary lines of plasmids were identified on the basis of restriction enzyme analysis. One was found exclusively in human isolates and another was found in pig isolates, while the third line consisted of plasmids from both sources. All R plasmids readily transferred to laboratory strains, and evidence was found for transfer to other biotypes of E. coli in the environment. The Tpr genes from representatives of the plasmid lines were cloned and compared by restriction analysis and by hybridization with two characterized Tpr dihydrofolate reductase genes. The sequences flanking the Tpr genes were different for each line, but all showed homology with the type 2 dihydrofolate reductase gene, irrespective of whether they were of human or animal origin. There was no hybridization to the type 1 gene. The remarkable degree of similarity among plasmids of the third line provided clear evidence of the exchange of plasmid-bearing E. coli between humans and pigs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015005      PMCID: PMC284158          DOI: 10.1128/AAC.29.5.807

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  R124, an fi R factor of a new compatibility class.

Authors:  R W Hedges; N Datta
Journal:  J Gen Microbiol       Date:  1972-07

4.  Persistence and spread of a chloramphenicol resistance-mediating plasmid in antigenic types of Escherichia coli, pathogenic for piglets.

Authors:  S T Jørgensen; J Grinsted; P Bennett; M H Richmond
Journal:  Plasmid       Date:  1980-09       Impact factor: 3.466

5.  Naturally occurring plasmids exhibiting incompatibility with members of incompatibility groups I and P.

Authors:  A J Grant; P I Bird; J Pittard
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

6.  Incompatibility among alpha-hemolytic plasmids studied after inactivation of the alpha-hemolysin gene by transposition of Tn802.

Authors:  F de la Cruz; J C Zabala; J M Ortiz
Journal:  Plasmid       Date:  1979-10       Impact factor: 3.466

7.  Protein expression in Escherichia coli minicells containing recombinant plasmids specifying trimethoprim-resistant dihydrofolate reductases.

Authors:  M E Fling; L P Elwell
Journal:  J Bacteriol       Date:  1980-02       Impact factor: 3.490

8.  Genetic and molecular characterization of R plasmids incompatible with R387 (IncK).

Authors:  H Tschäpe; E Tietze
Journal:  J Gen Microbiol       Date:  1980-06

9.  Plasmids encoding trimethoprim resistance in bacterial isolates from man and pigs.

Authors:  B J Mee; S M Nikoletti
Journal:  J Appl Bacteriol       Date:  1983-04

10.  Relatedness of chloramphenicol resistance plasmids in epidemiologically unrelated strains of pathogenic Escherichia coli from man and animals.

Authors:  S T Jørgensen
Journal:  J Med Microbiol       Date:  1983-05       Impact factor: 2.472

View more
  2 in total

1.  Mapping of trimethoprim resistance genes from epidemiologically related plasmids.

Authors:  I G Campbell; B J Mee
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 2.  Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance.

Authors:  L W Mayer
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.